Machine learning constructs a ferroptosis related signature for predicting prognosis and drug sensitivity in lung cancer

The FRS represents a powerful and clinically relevant tool for predicting the survival of lung cancer patients, offering new insights into personalized treatment and therapeutic decision-making.